Uncategorized

Clinic Dispensing Solutions

Medication dispensing has become a well-accepted practice for physicians looking to add value to the patient experience while increasing clinic revenue.  There are a number of approaches to pharmaceutical dispensing and a few gotchas.

Physician dispensing is the act of giving a patient prescription medication from the clinic rather than making him/her go to a pharmacy.  State laws require the physician to only dispense to his/her own patient and some states place additional limitations on dispensing from the clinic.  Dispensing clinics typically serve cash-paying or worker’s comp patients and focus on generic medications.

PCA’s dispensing solution involves distributing prepackaged pharmaceuticals directly to the clinic.  We take bulk medications and repackage them into unit-of-use sizes that fit typical prescription patterns.  Physicians can use our logbook system with manual labels or our software solution: RxTracker.  Either approach enables the clinic to safely and legally dispense to its patients.  Visit our www.pcameds.net to learn more about your options.

Schedule a free claims analysis now.

Let’s Talk now

Leader in AI-driven health benefits navigation Healthee partners with Northwind

Katherine Lurk | Mar 28th, 2025
A game-changer for employers looking to cut costs and gain control With healthcare costs continuing to rise, employers are seeking new ways to rein in spending without sacrificing the quality of benefits. This partnership enables Healthee clients to optimize prescription drug management, reducing costs through preferable generic drug pricing, high-touch chronic care programs, and more. … more »

continue reading

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading